These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
617 related items for PubMed ID: 27984115
1. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Ramalho-Carvalho J, Martins JB, Cekaite L, Sveen A, Torres-Ferreira J, Graça I, Costa-Pinheiro P, Eilertsen IA, Antunes L, Oliveira J, Lothe RA, Henrique R, Jerónimo C. Cancer Lett; 2017 Jan 28; 385():150-159. PubMed ID: 27984115 [Abstract] [Full Text] [Related]
5. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, Yang YZ, Moyer MP, Zhang HZ, Chen HQ, Liang Y, Qin HL. J Pathol; 2013 Jan 07; 229(1):12-24. PubMed ID: 22821729 [Abstract] [Full Text] [Related]
8. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop. Sengupta D, Deb M, Rath SK, Kar S, Parbin S, Pradhan N, Patra SK. Exp Cell Res; 2016 Aug 15; 346(2):176-87. PubMed ID: 27475839 [Abstract] [Full Text] [Related]
10. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells. Fujita Y, Kojima T, Kawakami K, Mizutani K, Kato T, Deguchi T, Ito M. Prostate; 2015 Oct 15; 75(14):1568-78. PubMed ID: 26074357 [Abstract] [Full Text] [Related]